COVID-19 Pandemic Clinical Trial
Official title:
An Open Label, Phase III Clinical Trial (Immunobridging Study) of INAVAC (Vaksin Merah Putih - UA-SARS CoV-2 (Vero Cell Inactivated)) in Healthy Population Aged 12 to 17 Years Old
This is an open label, phase III trial - immunobridging study. There will be only 1 group in the study. All subjects (12 to 17 years old) will receive INAVAC 5 µg dose. The vaccine will be administered with 2-dose schedule, intramuscularly, with 28 day interval. All subjects will be followed for 12 months. INAVAC is an inactivated vaccine made of SARS-CoV-2 virus isolated from a patient in Surabaya, composed with aluminium hydroxy gel, tween 80, and L-histidine, and this study will be the first phase III in adolescents.
This is an open label, phase III trial - immunobridging study. There will be only 1 group in the study. All subjects (12 to 17 years old) will receive INAVAC 5 µg dose. The vaccine will be administered with 2-dose schedule, intramuscularly, with 28 day interval. All subjects will be followed for 12 months. This study will have three interim and one full analysis The main focus is immunogenicity and safety or reactogenicity issues. Data Safety Monitoring Board will be commissioned for this study to evaluate safety data over the study period and to review any events that meet a specific study pausing rule or any other safety issue that may arise. They will review the 7 and 28 days safety data following the first dose of vaccine, and then the 7 and 28 days after the second dose. The immunogenicity data will be evaluated until 12 months after the second dose. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05197634 -
The Impact of Covid-19 Pandemic On The Children With Autism Spectrum Disorder
|
||
| Recruiting |
NCT05918939 -
UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study)
|
Early Phase 1 | |
| Completed |
NCT05383560 -
Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults
|
Phase 2 | |
| Active, not recruiting |
NCT05125874 -
Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization
|
N/A | |
| Completed |
NCT05517148 -
Effects of an Immersive Virtual Reality Intervention Combined With Mindfulness-based Stress Reduction
|
N/A | |
| Completed |
NCT05552989 -
Towards Better Preparedness for Future Catastrophes - Local Lessons-learned From COVID-19
|
||
| Completed |
NCT05543551 -
Effects of Diagrammatic Breathing With and Without Resistance in Post Covid Patients on ADLs
|
N/A | |
| Active, not recruiting |
NCT06272253 -
UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects
|
Early Phase 1 | |
| Active, not recruiting |
NCT05585567 -
A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5
|
Early Phase 1 | |
| Not yet recruiting |
NCT05381883 -
Mental Health of Professionals of the Silver Economy of New Aquitaine : Online Survey of Accommodation Establishments for Old People and Home Assistance Establishments
|
N/A | |
| Active, not recruiting |
NCT05582746 -
COVID-19 Testing and Vaccine Literacy for Women With Criminal Legal System Involvement
|
N/A | |
| Recruiting |
NCT05062681 -
RCT on the Efficacy of Dexamethasone Versus Methyl Prednisolone in Covid-19 Infected Patients With High Oxygen Flow
|
Phase 4 | |
| Completed |
NCT04697030 -
Burnout Among Adolescent Population During Covid-19 Lockdown in Pakistan
|
||
| Active, not recruiting |
NCT05419167 -
STEP-COVID: A Program for Pregnant Women During the SARS-CoV-2 Pandemic
|
Phase 1 | |
| Completed |
NCT06435390 -
Coronavirus Disease 2019 (COVID-19) Pandemic on the Oral Hygiene Status of Children
|
||
| Terminated |
NCT05553964 -
SARS-CoV-2 OTC At Home Test
|
N/A | |
| Completed |
NCT05596032 -
Prospective Study to Validate the Diagnostic Performance of IVD CAPSULE COVID-19-NP Test for the Detection of SARS-CoV-2
|
||
| Completed |
NCT05583812 -
A Study of FB2001 for Inhalation in Healthy Chinese Adults
|
Phase 1 | |
| Completed |
NCT05844410 -
Evaluation of Corticosteroids Use and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Study
|
||
| Completed |
NCT05123573 -
Self-Perceived in Medical Students Undergoing Distance Learning
|